Search
for
Sort by
Research 661–690 of 1000+
- 5α-Reductase inhibitors in androgenetic alopecia
- Alterations in androgen conjugate levels in women and men with alopecia
- Androgenic effects of oral contraceptives: Implications for patient compliance
- Expression of concern: potential risk for developing severe COVID-19 disease among anabolic steroid users
- Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- The role of androgen therapy
- COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?
- PLASMA TESTOSTERONE GLUCOSIDURONATE: A RELIABLE INDICATOR OF FEMALE HYPERANDROGENISM (IDIOPATHIC HIRSUTISM AND ANDROGENIC ALOPECIA)
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- TOPICAL MINOXIDIL THERAPY FOR ANDROGENIC ALOPECIA IN THE MIDDLE EAST
- Anti-androgen therapy in dermatology: a review
- Determination of rat 5α-reductase type 1 isozyme activity and its inhibition by novel steroidal oxazolines
- Markers of peripheral androgen action in vivo and in vitro
- Analysis of androgen receptor expression and activity in the mouse brain
- The Interrelation Between Hirsutism and Androgen Hormone Levels as Well as Serum TNFΑ Concentrations
- Androgen excess: a hallmark of polycystic ovary syndrome
- Steroid Hormones of Reproduction and Sexual Development
- Androgen effects on the skin
- Androgen Treatment in Women
- Urinary steroid analysis of women with effluvium
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Androgenetic alopecia, hirsutism and hypertrichosis
- Significance of the polyglutamine tract polymorphism in the androgen receptor
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- The Molecular Basis of Androgen Insensitivity
- Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i>
- <i>In Vitro</i>and<i>in Vivo</i>Structure-Activity Relationships of Novel Androgen Receptor Ligands with Multiple Substituents in the B-Ring
- Preparation of 4-aryl-2-trifluoromethylbenzonitrile derivatives as androgen receptor antagonists for topical suppression of sebum production